NCT04524702View on ClinicalTrials.gov

Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 14, 2020

Primary Completion Date

August 14, 2024

Study Completion Date

August 14, 2024

Conditions
Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8
Interventions
DRUG

Gemcitabine

Given IV

DRUG

Hydroxychloroquine

Given PO

DRUG

Nab-paclitaxel

Given IV

DRUG

Paricalcitol

Given IV

Trial Locations (3)

30308

Emory University Hospital Midtown, Atlanta

30322

Emory University Hospital/Winship Cancer Institute, Atlanta

30342

Emory Saint Joseph's Hosptial, Atlanta

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Emory University

OTHER